As on Wednesday, DBV Technologies ADR (NASDAQ: DBVT) started slowly as it slid -4.64% to $3.29, before settling in for the price of $3.45 at the close. Taking a more long-term approach, DBVT posted a 52-week range of $2.20-$10.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was 35.36%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 33.44%. This publicly-traded company’s shares outstanding now amounts to $20.51 million, simultaneously with a float of $20.13 million. The organization now has a market capitalization sitting at $67.48 million. At the time of writing, stock’s 50-day Moving Average stood at $3.45, while the 200-day Moving Average is $5.06.
DBV Technologies ADR (DBVT) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. DBV Technologies ADR’s current insider ownership accounts for 1.86%, in contrast to 13.82% institutional ownership. According to the most recent insider trade that took place on Nov 25 ’24, this organization’s Chief Medical Officer sold 565 shares at the rate of 0.57, making the entire transaction reach 322 in total value, affecting insider ownership by 111,110. Preceding that transaction, on Nov 22 ’24, Company’s Chief Medical Officer sold 342 for 0.53, making the whole transaction’s value amount to 181. This particular insider is now the holder of 111,675 in total.
DBV Technologies ADR (DBVT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
DBV Technologies ADR’s EPS increase for this current 12-month fiscal period is 33.44% and is forecasted to reach -4.56 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 21.22% through the next 5 years, which can be compared against the 35.36% growth it accomplished over the previous five years trading on the market.
DBV Technologies ADR (NASDAQ: DBVT) Trading Performance Indicators
Let’s observe the current performance indicators for DBV Technologies ADR (DBVT). It’s Quick Ratio in the last reported quarter now stands at 2.22. The Stock has managed to achieve an average true range (ATR) of 0.36.
In the same vein, DBVT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.31, a figure that is expected to reach -1.11 in the next quarter, and analysts are predicting that it will be -4.56 at the market close of one year from today.
Technical Analysis of DBV Technologies ADR (DBVT)
Through scrutinizing the latest numbers posted by the [DBV Technologies ADR, DBVT], it can be observed that its last 5-days Average volume of 0.29 million was better the volume of 51256.0, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 30.38% While, its Average True Range was 0.36.
Raw Stochastic average of DBV Technologies ADR (DBVT) in the period of the previous 100 days is set at 33.45%, which indicates a major fall in contrast to 46.21% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 147.36% that was higher than 88.31% volatility it exhibited in the past 100-days period.
